ȨÀ¸·Î
·Î±×ÀÎ
ȨÆäÀÌÁö ȸ¿ø°¡ÀÔ
ENGLISH
÷´ÜÀç»ýÀÇ·á»ê¾÷Çùȸ ¹Ù·Î°¡±â
Çùȸ¼Ò°³
Àλ縻
¼³¸³ÃëÁö/¿¬Çõ
Á¶Á÷µµ
ÁÖ¿äÈ°µ¿
ã¾Æ¿À½Ã´Â ±æ
ȸ¿ø»ç
ȸ¿øÇöȲ
ȸ¿ø°¡ÀÔ
ȸ¿ø»ç¼Ò½Ä
È°µ¿¼Ò½Ä
Çà»çÀÏÁ¤
GALLERY
À§¿øȸ È°µ¿
¾Ë¸²¸¶´ç
°øÁö»çÇ×
¾ð·Ðº¸µµ
ÀÚ·á½Ç
¸Þ´º´Ý±â
ȨÀ¸·Î
·Î±×ÀÎ
ȨÆäÀÌÁö ȸ¿ø°¡ÀÔ
Çùȸ ¼Ò°³
ȸ¿ø»ç
Çà»ç¾È³»
¾Ë¸²¸¶´ç
Àλ縻
¼³¸³ÃëÁö/¿¬Çõ
ÁÖ¿äÈ°µ¿
Á¶Á÷µµ
ã¾Æ¿À½Ã´Â ±æ
ȸ¿øÇöȲ
ȸ¿ø°¡ÀÔ
ȸ¿ø»ç¼Ò½Ä
Çà»çÀÏÁ¤
GALLERY
À§¿øȸ È°µ¿
°øÁö»çÇ×
¾ð·Ðº¸µµ
ÀÚ·á½Ç
¾Ë¸²¸¶´ç
°øÁö»çÇ×
°øÁö»çÇ×
¾ð·Ðº¸µµ
ÀÚ·á½Ç
°øÁö»çÇ×
ÀÚ·á½Ç
ÀÚ·á½Ç
°øÁö»çÇ×
Ȩ ¹Ù·Î°¡±â
¾Ë¸²¸¶´ç
°øÁö»çÇ×
¹øÈ£
Á¦¸ñ
ÀÛ¼ºÀÚ
µî·ÏÀÏ
Á¶È¸¼ö
÷ºÎ
[°øÁö]
÷´ÜÀç»ýÀÇ·á»ê¾÷Çùȸ °øÀ͹ýÀÎ ½Å±Ô ÁöÁ¤ ¾Ë¸²
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2023-10-05
Á¶È¸¼ö
314
[°øÁö]
»ç´Ü¹ýÀÎ ¼³¸³ ¹× »ç¹«±¹ ÀÌÀü ¾È³»
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2023-01-02
Á¶È¸¼ö
418
[°øÁö]
÷´ÜÀç»ýÀÇ·á»ê¾÷Çùȸ(CARM) ´º½º·¹ÅÍ
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2022-05-04
Á¶È¸¼ö
461
[°øÁö]
¿¬È¸ºñ ³³ºÎ ¹æ½Ä º¯°æ ¾È³» (Àç)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2022-03-03
Á¶È¸¼ö
427
329
[À¯°ü±â°ü/±¹°¡ÀÓ»ó½ÃÇèÁö¿øÀç´Ü] º¸°Çº¹ÁöºÎ Àå°ü ǥâ ÀÓ»ó½ÃÇè À¯°ø Èĺ¸ Ãßõ Á¢¼ö¾È³» (4.3~4.9)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-04-04
Á¶È¸¼ö
24
÷ºÎÆÄÀÏ
328
[À¯°ü±â°ü/±¹¸³¾Ï¼¾ÅÍ] Ç׾Ͻžà½ÅÄ¡·á°³¹ß»ç¾÷´Ü GMP Àη ä¿ë °ø°í (~4/26)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-29
Á¶È¸¼ö
68
327
[À¯°ü±â°ü/±¹°¡ÀÓ»ó½ÃÇèÁö¿øÀç´Ü] º¸°Çº¹ÁöºÎ Àå°ü ǥâ ÀÓ»ó½ÃÇè À¯°ø Èĺ¸ Ãßõ »çÀü¾È³»
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-28
Á¶È¸¼ö
32
÷ºÎÆÄÀÏ
326
[ÃæûºÏµµ] ÃæºÏ ÷´ÜÀç»ý¹ÙÀÌ¿À ±Û·Î¹ú Çõ½Å ±ÔÁ¦ÀÚÀ¯Æ¯±¸ °øûȸ °³ÃÖ ¾È³» (3/29)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-26
Á¶È¸¼ö
35
÷ºÎÆÄÀÏ
325
[ȸ¿ø»ç/½á¸ðÇǼŻçÀ̾ðƼÇÈ] 2024 Bio Startup Power up ¼¼¹Ì³ª ÃÊû ¹× »çÀüµî·Ï ¾È³»
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-25
Á¶È¸¼ö
54
324
[±¹¿ÜÀ¯°üÇÐȸ] Á¦7ȸ APACRM °³ÃÖ ¹× »çÀüµî·Ï ¾È³» (4/25)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-25
Á¶È¸¼ö
44
÷ºÎÆÄÀÏ
323
[À¯°ü±â°ü/KIDS] 2024³â ÷´Ü¹ÙÀÌ¿ÀÀǾàÇ° ±ÔÁ¦°úÇÐ Àü¹®±³À° Á¦Á¶Ç°Áú°ü¸® °úÁ¤(±âº») ±³À° ¾È³» (~3/29)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-14
Á¶È¸¼ö
51
÷ºÎÆÄÀÏ
322
[ȸ¿ø»ç/¿À°¡³ëÀ̵å»çÀ̾ð½º] ODC24 'The Next Normal : Living With Organoids' ½ÉÆ÷Áö¾ö °³ÃÖ ¾È³» (~3/31)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-14
Á¶È¸¼ö
39
÷ºÎÆÄÀÏ
321
[À¯°ü±â°ü/KTR] À¯ÀüÀÚÄ¡·áÁ¦ »ý»ê °íµµÈ¸¦ À§ÇÑ °ø°ø CDMO ¹× ¿ø½ºÅé Ç÷§Æû ±¸Ãà ¼ö¿äÁ¶»ç ¾È³» (~3/20)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-14
Á¶È¸¼ö
28
320
[À¯°ü±â°ü/Çѱ¹»ê¾÷±â¼ú±âȹÆò°¡¿ø] ÷´Ü¹ÙÀÌ¿ÀÀǾàÇ° ºÐ¾ß ±â¾÷ ÅõÀÚ °èȹ Á¶»ç ÇùÁ¶¿äû (~3/8 15:00)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-06
Á¶È¸¼ö
34
÷ºÎÆÄÀÏ
319
[ȸ¿ø»ç/Áø½ºÅ©¸³Æ® ÇÁ·Î¹ÙÀÌ¿À] Cell Therapy Development Strategies to Expand Patient Access ¿þºñ³ª °³ÃÖ ¾È³» (3/28)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-06
Á¶È¸¼ö
29
÷ºÎÆÄÀÏ
318
[À¯°üÇà»ç/informa connect] BioProcess International US West °³ÃÖ ¹× »çÀüµî·Ï ¾È³» (3/11-14 PST)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-22
Á¶È¸¼ö
46
÷ºÎÆÄÀÏ
317
[½Ä¾àó] 2024³â ¹ÙÀÌ¿ÀÀǾàÇ° Çã°¡¤ý½É»ç ¿ª·® °È ¼³¸íȸ(BioUpdate) °³ÃÖ ¾È³» (3/11)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-19
Á¶È¸¼ö
74
÷ºÎÆÄÀÏ
316
ÇູÇÑ ¼³ ¸íÀý º¸³»½Ã±â ¹Ù¶ø´Ï´Ù.
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-08
Á¶È¸¼ö
36
315
[À¯°ü±â°ü/KFRM] 2024³âµµ ¹üºÎóÀç»ýÀÇ·á±â¼ú°³¹ß»ç¾÷ ½Å±ÔÁö¿ø ´ë»ó°úÁ¦ °ø°í(³»¿ª»ç¾÷ 3) (~2/28)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-08
Á¶È¸¼ö
45
÷ºÎÆÄÀÏ
314
[½Ä¾àó] ÷´Ü¹ÙÀÌ¿ÀÀǾàÇ° ½ÃÆÇ ÈÄ Ç°ÁúÆò°¡¸¦ À§ÇÑ °í·Á»çÇ×[¹Î¿øÀÎ ¾È³»¼] ¹ß°£ ¾È³»
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-07
Á¶È¸¼ö
36
÷ºÎÆÄÀÏ
313
[ÃæûºÏµµ] ÷´Ü´ëü½ÃÇè¹ý »êÇп¬°ü Á¤º¸±³·ù ½ÉÆ÷Áö¾ö °³ÃÖ ¾È³» (2/7)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-06
Á¶È¸¼ö
27
÷ºÎÆÄÀÏ
312
[À¯°ü±â°ü/°úÇбâ¼úÀü·«¿¬±¸¼Ò] ÷´Ü¹ÙÀÌ¿À Ä¡·áÁ¦ ¸ÂÃãÇü Á¦Á¶°øÁ¤ Çõ½Å»ç¾÷ - ¹Î°£±â¾÷ Âü¿©ÀÇÇâ Á¶»ç ¾È³» (~2/9 12:00)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-01-29
Á¶È¸¼ö
59
÷ºÎÆÄÀÏ
311
[ÃæûºÏµµ] 2024 ¡¸ÃæºÏ ÷´ÜÀç»ý¹ÙÀÌ¿À ±Û·Î¹ú Çõ½Å Ư±¸¡¹ »ç¾÷¼³¸íȸ °³ÃÖ ¾È³» (1/19)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-01-17
Á¶È¸¼ö
68
÷ºÎÆÄÀÏ
310
[À¯°ü±â°ü/RMAF] ÷´ÜÀç»ýÀÇ·á ½Ç½À±³À°À» À§ÇÑ GMP ½Ã¼³ Á¦°ø °¡´É ±â¾÷ Á¶»ç (~1/23)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-01-16
Á¶È¸¼ö
72
÷ºÎÆÄÀÏ
1
2
3
4
5
Á¦ ¸ñ
³» ¿ë
Á¦¸ñ + ³»¿ë
ÀÛ¼ºÀÚ
¾ÆÀ̵ð
°Ë»ö